Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Biotechnology Index NYSE ETF (FBT)

Biotechnology Index NYSE ETF (FBT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family First Trust Portfolios
  • Assets Under Management 1,933,529,000
  • Shares Outstanding, K 11,050
  • 60-Month Beta 0.98
Trade FBT with:
  • Price/Earnings ttm 29.63
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 0.020 on 09/23/15
  • Management Fee 0.55%
  • Sectors:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 20.09%
  • Historical Volatility 13.67%
  • IV Percentile 11%
  • IV Rank 13.20%
  • IV High 36.33% on 10/28/20
  • IV Low 17.62% on 07/01/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 5
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 0
  • Open Int (30-Day) 0

Price Performance

See More
Period Period Low Period High Performance
1-Month
169.57 +1.96%
on 09/14/21
176.07 -1.80%
on 09/02/21
+0.64 (+0.37%)
since 08/24/21
3-Month
163.51 +5.74%
on 07/27/21
176.07 -1.80%
on 09/02/21
-0.79 (-0.45%)
since 06/24/21
52-Week
150.33 +15.01%
on 10/30/20
186.51 -7.30%
on 02/10/21
+20.50 (+13.45%)
since 09/24/20

Most Recent Stories

More News
Pfizer Vaccine Approval Triggers a Surge in Biotech ETFs

The biotech space has once again come under the spotlight as the FDA has granted the first full U.S. approval to Pfizer (PFE)/BioNTech's (BNTX) coronavirus vaccine.

PFE : 43.94 (-0.57%)
IBB : 170.49 (-1.97%)
XBI : 130.37 (-2.03%)
BBH : 214.61 (-1.83%)
FBT : 172.90 (-1.17%)
BTEC : 56.41 (-2.07%)
BNTX : 333.48 (-5.53%)
Biotech ETFs to Benefit From Latest Booster Update

The U.S. government's plans to make COVID-19 vaccine booster shots available from next month will likely increase the profits of vaccine makers.

PFE : 43.94 (-0.57%)
MRNA : 430.14 (-5.38%)
IBB : 170.49 (-1.97%)
XBI : 130.37 (-2.03%)
BBH : 214.61 (-1.83%)
FBT : 172.90 (-1.17%)
BTEC : 56.41 (-2.07%)
BNTX : 333.48 (-5.53%)
Delta Variant Surge Brings Biotech ETFs in Focus

The biotech sector seems like a lucrative investment space as the delta variant of coronavirus continues to spread.

SNY : 47.94 (-1.60%)
AAPL : 146.92 (+0.06%)
TGT : 241.44 (-0.51%)
WMT : 143.17 (+0.28%)
MRNA : 430.14 (-5.38%)
IBB : 170.49 (-1.97%)
TBIO : 37.36 (-0.13%)
FB : 352.96 (+2.02%)
GOOGL : 2,844.30 (+0.71%)
XBI : 130.37 (-2.03%)
BBH : 214.61 (-1.83%)
FBT : 172.90 (-1.17%)
BTEC : 56.41 (-2.07%)
Biogen's Alzheimer's Drug Approval Puts Biotech ETFs in Spotlight

The FDA's approval of the first new drug to treat Alzheimer's disease in about 20 years has attracted investors' attention toward the biotech sector while sparking new controversies.

BIIB : 291.71 (-0.51%)
IBB : 170.49 (-1.97%)
XBI : 130.37 (-2.03%)
BBH : 214.61 (-1.83%)
FBT : 172.90 (-1.17%)
BTEC : 56.41 (-2.07%)
Top-Performing Biotech ETFs of Last Week

Investors may want to tap the bullishness in the sector with the best biotech ETFs of last week.

BIIB : 291.71 (-0.51%)
FBT : 172.90 (-1.17%)
SBIO : 46.54 (-1.75%)
BTEC : 56.41 (-2.07%)
ARKG : 78.65 (-3.35%)
GNOM : 23.38 (-2.58%)
ORPH : 4.40 (-2.44%)
CLOV : 7.73 (-2.15%)
Top COVID-19 Vaccine Stories of May Put Biotech ETFs in Focus

Let's take a look at some top coronavirus vaccine stories of May and the possible impact they can have on biotech ETFs.

SNY : 47.94 (-1.60%)
AZN : 60.35 (+1.46%)
PFE : 43.94 (-0.57%)
MRNA : 430.14 (-5.38%)
IBB : 170.49 (-1.97%)
XBI : 130.37 (-2.03%)
BBH : 214.61 (-1.83%)
FBT : 172.90 (-1.17%)
BTEC : 56.41 (-2.07%)
BNTX : 333.48 (-5.53%)
CVAC : 58.04 (+0.33%)
Biotech ETFs to Suffer as US Backs IP Waiver for COVID-19 Vaccines

The Biden administration recently informed about supporting the waiver of intellectual property protections for COVID-19 vaccines that has been proposed by South Africa and India.

JNJ : 164.36 (-0.30%)
AZN : 60.35 (+1.46%)
PFE : 43.94 (-0.57%)
MRNA : 430.14 (-5.38%)
IBB : 170.49 (-1.97%)
XBI : 130.37 (-2.03%)
BBH : 214.61 (-1.83%)
FBT : 172.90 (-1.17%)
BTEC : 56.41 (-2.07%)
Top COVID-19 Vaccine Stories of April Put Biotech ETFs in Focus

Let's take a look at some top coronavirus vaccine stories of April and the possible impact they can have on biotech ETFs.

JNJ : 164.36 (-0.30%)
AZN : 60.35 (+1.46%)
NVAX : 248.16 (-3.55%)
IBB : 170.49 (-1.97%)
XBI : 130.37 (-2.03%)
BBH : 214.61 (-1.83%)
FBT : 172.90 (-1.17%)
BTEC : 56.41 (-2.07%)
OCGN : 7.53 (-1.05%)
IBRX : 10.26 (-4.20%)
Top COVID-19 Vaccine Stories of March Put Biotech ETFs in Focus

Investors are closely tracking the progress in coronavirus vaccine development amid the pandemic's renewed resurgence with multiple mutants.

AZN : 60.35 (+1.46%)
PFE : 43.94 (-0.57%)
MRNA : 430.14 (-5.38%)
NVAX : 248.16 (-3.55%)
IBB : 170.49 (-1.97%)
XBI : 130.37 (-2.03%)
BBH : 214.61 (-1.83%)
FBT : 172.90 (-1.17%)
BTEC : 56.41 (-2.07%)
BNTX : 333.48 (-5.53%)
A Guide to Biotech ETF Investing Amid the Coronavirus Crisis

The biotech space had an impressive run on the bourses in 2020 as the coronavirus pandemic triggered a race to roll out vaccine and treatment.

PFE : 43.94 (-0.57%)
MRNA : 430.14 (-5.38%)
LLY : 231.68 (-0.22%)
IBB : 170.49 (-1.97%)
CNCR : 31.00 (-0.88%)
XBI : 130.37 (-2.03%)
BBH : 214.61 (-1.83%)
FBT : 172.90 (-1.17%)
SBIO : 46.54 (-1.75%)
PBE : 77.50 (-0.78%)
BTEC : 56.41 (-2.07%)
ARKG : 78.65 (-3.35%)
BNTX : 333.48 (-5.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The First Trust NYSE Arca Biotechnology Index Fund is and exchange-traded index fund. The investment objective of the fund is to replicate as closely as possible, before fees and expenses, the price and yield of the NYSE Arca Biotechnology Index. The NYSE Arca Biotechnology Index is an equal dollar weighted...

See More

Key Turning Points

3rd Resistance Point 175.32
2nd Resistance Point 174.77
1st Resistance Point 173.83
Last Price 172.90
1st Support Level 172.34
2nd Support Level 171.79
3rd Support Level 170.85

See More

52-Week High 186.51
Last Price 172.90
Fibonacci 61.8% 172.69
Fibonacci 50% 168.42
Fibonacci 38.2% 164.15
52-Week Low 150.33

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar